| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
Institute of Pathology [A. F., A. W., K. P., M. R., E. S., A. T., H. H., M. J. A.] and Institute of Mammalian Genetics [J. G.], GSF-National Research Center for Environment and Health, D85764 Neuherberg; Institute of Pathology, Technical University, D81675 Munich, [A. W., H. H.]; Institute of Animal Physiology, Ludwig-Maximilians-University, D80539 Munich [K. W.]; and Department of Ophthalmology, Section of Immunobiology, Ludwig-Maximilians-University, D80336 Munich [G. W.], Germany
We describe a novel hereditary cancer syndrome in the rat that is transmitted by a recessive gene mutation. Animals exhibiting the mutant phenotype develop multiple neuroendocrine malignancies within the first year of life. The endocrine neoplasia is characterized by bilateral adrenal pheochromocytoma, multiple extra-adrenal pheochromocytoma, bilateral medullary thyroid cell neoplasia, bilateral parathyroid hyperplasia, and pituitary adenoma. The appearance of neoplastic disease is preceded by the development of bilateral juvenile cataracts. Although the spectrum of affected tissues is reminiscent of human forms of multiple endocrine neoplasia (MEN), no germ-line mutations were detected in the Ret or Menin genes that are responsible for the dominantly inherited MEN syndromes in humans. Segregation studies in F1 and F2 crosses yielded frequencies of affected animals entirely consistent with a recessive autosomal mode of inheritance. The lack of the phenotype in F1 animals effectively excludes a germ-line tumor suppressor gene mutation as the causal event. The absence of mutation of known MEN genes and the unique constellation of affected tissues, plus the recessive mode of inheritance, lead us to conclude that the mutation of an as yet unknown gene is responsible for this syndrome of inherited neuroendocrine cancer.
This article has been cited by other articles:
![]() |
M. Georgitsi, A. Raitila, A. Karhu, R. B. van der Luijt, C. M. Aalfs, T. Sane, O. Vierimaa, M. J. Makinen, K. Tuppurainen, R. Paschke, et al. Germline CDKN1B/p27Kip1 Mutation in Multiple Endocrine Neoplasia J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3321 - 3325. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karhu and L. A. Aaltonen Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update Hum. Mol. Genet., April 15, 2007; 16(R1): R73 - R79. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Pellegata, L. Quintanilla-Martinez, H. Siggelkow, E. Samson, K. Bink, H. Hofler, F. Fend, J. Graw, and M. J. Atkinson Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans PNAS, October 17, 2006; 103(42): 15558 - 15563. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L.M. Dahia, K. Hao, J. Rogus, C. Colin, M. A.G. Pujana, K. Ross, D. Magoffin, N. Aronin, A. Cascon, C. Y. Hayashida, et al. Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics Cancer Res., November 1, 2005; 65(21): 9651 - 9658. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |